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Small spherical viruses are paradigms of supramolecular self-assembly. Identifying the specific
structural determinants for virus assembly provides guidelines to develop new antiviral drugs or
engineer modified viral particles for medical or technological applications. However, very few
systematic studies have been carried out so far to identify those chemical groups at interfaces
between virus capsid subunits that are important for viral assembly and function. Foot-and-mouth
disease virus (FMDV) and other picornaviruses are assembled in a stepwise process in which
different protein–protein interfaces are formed: 5 protomeric subunits oligomerize to form a
pentameric intermediate, and 12 of these stable pentameric building blocks associate to form a labile
capsid. In this study, a systematic mutational analysis revealed that very few amino acid side chains
involved in substantial interactions between protomers within each pentamer are individually required
for virus infectivity. This result contrasts sharply with the previous finding that most amino acid side
chains involved in interactions between pentamers during the next assembly step are individually
required for infectivity. The dramatic difference in sensitivity to single mutations between the two
types of protein–protein interfaces in FMDV is discussed in terms of possible structural strategies
for achieving self-assembly and genome uncoating in the face of diverse selective constraints.
Received 27 March 2015
Accepted 15 May 2015
INTRODUCTION
Virus morphogenesis entails a cascade of molecular recog-
nition events in which capsid protein subunits and the
viral genome are involved (for recent reviews see Agbandje-
McKenna & McKenna, 2011; Aksyuk & Rossmann, 2011;
Domitrovic et al., 2013; Mateu, 2013a, 2013b; Veesler &
Johnson, 2012; Zlotnick & Mukhopadhyay, 2011). Inter-
actions between viral capsid subunits have been identified
in atomic or quasi-atomic structural models determined by
X-ray crystallography or, in some cases, by high-resolution
cryoelectron microscopy or a combination of structural tech-
niques. Theoretical estimates of the energetics of intersubunit
interactions have been obtained for many viruses; the VIPER
database provides abundant data on both icosahedral
virus structures and calculated subunit interaction energies
(Carrillo-Tripp et al., 2009). Many structure-based functional
studies have provided mechanistic insights into assembly, as
well as stability, dynamics, function and evolution, of virus
particles (Agbandje-McKenna & McKenna, 2011; Mateu,
2013b). Mutational analyses have addressed the roles of
selected capsid residues in these processes. Studies by ala-
nine-scanning mutagenesis have yielded a residue-by-residue
functional dissection of protein–protein or protein–nucleic
acid interfaces in a few virus particles (del Alamo et al., 2003;
Forshey et al., 2002; Ganser-Pornillos et al., 2004; Kim et al.,
2011; Mateo et al., 2003; Murray et al., 2007; Pe´rez et al.,
2011; Reguera et al., 2004, 2005; von Schwedler et al., 2003;
Wu et al., 2000; Zhang et al., 2010). These studies are also
contributing to developing novel applications in biomedicine,
biotechnology and nanotechnology, including antiviral drugs
(Bocanegra et al., 2012), engineered virus particles for vaccines,
gene therapy, drug delivery diagnosis, biomaterials and nano-
devices (Ba´rcena&Blanco, 2013; Bittner et al., 2013; Flenniken
et al., 2009; Glasgow & Tullman-Ercek, 2014; Li & Wang,
2014; Mateu, 2011; Smith et al., 2013; Wen et al., 2013).
They are also inspiring the design of self-assembling non-
biological nanostructures (Lamarre & Ryadnov, 2011).
Foot-and-mouth disease virus (FMDV) (Grubman & Baxt,
2004; Jamal & Belsham, 2013; Mahy, 2005; Sobrino &
Domingo, 2004) is both an excellent model for structure–
function studies of virus assembly and an economically
very important pathogen (Thompson et al., 2002)
for which new control strategies are required (Fowler &
Barnett, 2012; Paton et al., 2009; Rodriguez & Grubman,
2009). The P53 (T51) icosahedral capsid of FMDV
(Acharya et al., 1989; Curry et al., 1996; Fry et al., 1999;
Lea et al., 1994) (Fig. 1a) is formed by 60 copies of each
of three proteins (VP1, VP2, VP3) and a small internal
polypeptide (VP4), and contains a single-stranded RNA
genome. FMDV and other picornaviruses are assembled
in the host cell in a stepwise process: First, a protomeric
subunit made of one copy of each VP (as a single
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polyprotein, P1) is folded; the folded P1 protomer is then
proteolytically processed; five processed protomers oligo-
merize to form a stable pentameric intermediate; and, finally,
12 pentamers associate to form the complete capsid (Fig. 1a).
The viral RNAmay be co-assembled at this stage to yield the
complete virion (Rueckert, 1996). Viral genome uncoating
during infection by FMDV involves the acid-induced dis-
sociation of the labile capsid into pentamers (Carrillo
et al., 1985; Baxt, 1987). FMD virions are also very sensitive
to thermal dissociation, even at neutral pH and low tempera-
tures. As current FMD vaccines are based on the immuno-
genicity of chemically inactivated but structurally intact
virons, FMDV thermolability constitutes a problem for the
adequate control of this disease (Hegde et al., 2009). Struc-
tural studies and mutational analyses of FMDV are contri-
buting to understanding the molecular determinants of
assembly and genome uncoating, and the engineering of
viral particles of increased thermostability for the develop-
ment of improved vaccines (Mateo et al., 2008; Porta et al.,
2013; Rinco´n et al., 2014).
In previous structure–function studies on FMDV assembly
and stability, we focused on the interfaces between penta-
meric subunits which are involved both in the last capsid
assembly step and in its acid- or heat-induced disassembly.
A systematic mutational analysis by alanine-scanning of the
functional role of each of the 42 side chains (per protomer)
involved in interpentamer interactions in a foot-and-mouth
disease (FMD) virion (Fig. 1b) was carried out (Mateo et al.,
2003). The results revealed that the vast majority of amino
acid side chains at the interpentamer interfaces, even those
that participate only in a few van der Waals (vdW) interpen-
tamer contacts, are critically required for normal completion
of the infectious cycle. This observation suggested that the
last capsid assembly step during FMDV morphogenesis is
very sensitive to single mutations.
In the present study we have investigated the functional
role of individual capsid amino acid residues involved
in the previous FMDV assembly step, the interaction of
capsid protomers to form individual pentamers (Fig. 1b).
A thorough functional dissection by alanine-scanning of
the interprotomer interfaces in the FMD virion was carried
out, and the results were compared with those we had pre-
viously obtained for interpentamer interfaces in the same
virion. The comparison revealed extreme differences
between both interfaces regarding the functional tolerance
to mutation of residues in either interface. The structural
basis of such differences and the implications for virus
function and evolution are discussed.
RESULTS
Analysis of the interprotomer interactions within a
pentamer in the FMD virion
Analysis of the intersubunit interactions in the crystal
structure of the FMDV C-S8c1 virion (Lea et al., 1994)
revealed that each protomer–protomer interface within
: Group I or II
1
2
3
: Group III or IV
: Untested (weak interactions)
(a) (b) (c)
Fig. 1. Intersubunit interfaces in the FMDV capsid. (a) Scheme of the FMDV capsid architecture. Numbers 1, 2 and 3,
respectively, denote VP1, VP2 and VP3, which form one of the 60 protomeric subunits. Five protomers form a pentameric
subunit (delimited by cyan lines). A neighbouring pentamer is delimited by violet lines. Icosahedral symmetry axes are
indicated (fivefold, pentagon; threefold, triangle; twofold, diamond). (b) Atomic model of a pentamer based on the crystal
structure of the C-S8c1 virion (Lea et al., 1994). In one of the five protomers, the VP1, VP2 and VP3 subunits are coloured
as in (a). For this protomer, the residues whose side chains are involved in interpentamer interfaces are represented as white
space-filling models; and the residues whose side chains are involved in interprotomer interfaces within the pentamer are
represented as yellow (apolar side chains) or orange (polar side chains) space-filling models. (c) Close-up view of a
protomer–protomer interface within the pentamer. Interfacial residues represented as space-filling models are those whose
side chain is involved in interprotomer interactions. Residues analysed are coloured according to the effect on infectivity
caused by their individual mutation to alanine (see text and Table 2). Magenta, residues belonging to Group I or II; cyan,
residues belonging to Group III or IV. The side chains of residues in white were only involved in one or two VdW interproto-
mer contacts, and were not analysed.
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the same pentamer involves 93 amino acid residues belong-
ing to either protomer (Fig. 1b). As many as 45 of these
residues participate in protomer–protomer association
only through a few interactions that involve main chain
or Cb atoms exclusively. In principle, these interactions
may be preserved even if these residues are mutated (to ala-
nine or any other residue except glycine), either in nature
or in the laboratory. Thus, we focused exclusively on the
48 residues whose side chains (beyond the Cb) participate
in direct interprotomer interactions that would be removed
by mutation to alanine (Fig. 1c). Of these, 20 side chains
are fundamentally apolar and form a string of buried
hydrophobic patches along this narrow but extended pro-
tein–protein interface. Two of these side chains correspond
to tyrosines (mainly hydrophobic, but involved in hydro-
gen bonds through their hydroxyl groups). The remaining
28 side chains are fundamentally polar; 10 of them are
involved in interprotomer vdW interactions, while 18
others participate also in a total of 17 hydrogen bonds
and two salt bridges.
Based on the above analysis, we initially chose alanine-
scanning every interfacial residue whose side chain
participates in more than two vdW contacts (including
carbon–carbon contacts that bury hydrophobic surface),
and/or any hydrogen bond or salt bridge between proto-
mers. Six of these residues participate only in pairwise
contacts (N1091–Y3169, K1085–E1175, K2217–E3138); as
mutation of only one residue in each pair would be
enough to remove the corresponding interactions, only
one residue per pair was mutated. Two residues (L1205
and L1206) were excluded because they were located very
close to the polyprotein P1 C terminus, outside of the
segment in the mutagenized recombinant plasmid that is
subcloned in the FMDV infectious clone. As these two
residues are involved only in minor interactions between
protomers, we considered it unnecessary to include them
among the already large and highly representative ensemble
of interfacial residues to be tested. To sum up, 19 residues
per protomer whose side chains are together involved in
nearly all but the presumably weakest interprotomer inter-
actions were selected for mutation (Table 1, Fig. 1c).
As representatives of the interfacial residues whose side
chains participate only in presumably very weak inter-
actions (one or two vdW contacts), residues M3130 and
V3215 were additionally chosen for mutation (Table 1).
Effect of individual mutations at the interprotomer
interfaces in FMDV in host cell infection and
production of viral progeny
Mutation to alanine was used to remove every interaction of
the original side chain (beyond Cb), without introducing
any other interaction and with the lowest probability of
altering the main chain conformation. The 21 chosen
alanine mutations were introduced in the FMDV infectious
clone, the corresponding viral RNAs were obtained, and
equal amounts of them were used to transfect susceptible
cells in parallel with the same amount of non-mutated con-
trol RNA. The viral progeny produced at different times
after transfection were quantified by titration, and the
titres were normalized with respect to the one obtained for
the non-mutated control in the same experiment. After
the effects of each mutation in FMDV infectivity, the
mutants were classified in four groups (Table 2) as follows.
Group I (19 % of the mutants analysed): this group
comprised four lethal mutants that yielded no detectable
progeny at any time post-transfection (p.t.).
Group II (5 % of the mutants): this group comprised only
one mutant that showed a significantly reduced progeny at
any time p.t., and comparatively small lysis plaques.
Group III (19 % of the mutants): this group comprised
four mutants that showed a significant reduction in titre
at short times p.t., but that reached titres similar to that
of the non-mutated control at longer times. Sequencing
the virus population recovered at the longest times con-
firmed that the original mutation was still present and
that no accompanying mutations had been fixed. All
these results indicate that these mutations may decrease
the multiplication rate of the virus, but they clearly have
no effect on its intrinsic infectivity.
Group IV (57 % of the mutants): this group comprised 12
mutants that showed progeny titres and plaque sizes simi-
lar to that of the non-mutated control at any time p.t.
Mutants N1060A and N1100A consistently showed some-
what increased (three- to ninefold) titres compared with
the control; we were unable to find a likely cause for this
moderate increase in infectivity.
In summary, the individual removal of over 80 % of the 21
side chains analysed at each of the five interprotomer inter-
faces in each of the 12 pentamers in the FMDV capsid had
no significant effect in viral progeny production or plaque
size (about 60 %), or led only to some delay in particle pro-
duction (about 20 %). In contrast, fewer than 20 % of the
side chains proved to be critical for virus infection.
Effect of individual mutations at the interprotomer
interfaces in steps previous to protomer–
protomer association
Some of the mutated side chains are involved not only in
interprotomer interactions, but also in intraprotomer inter-
actions; in addition, some of these side chains are partially
exposed on the virion surface and could participate in inter-
actions with other molecules during the viral cycle. Thus, of
the few functionally critical residues at the interprotomer
interfaces, even fewer could be important for protomer–pro-
tomer recognition during virus assembly. This possibility is
suggested by the lack of correlation between the observed
effect of each mutation on viral production (Table 2), and
the reduction in interaction energy between protomers
caused by that mutation, based on predictions in the
VIPER database (Carrillo-Tripp et al., 2009). As expected,
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truncation of most (albeit not all) side chains involved in
only a few interprotomer vdW interactions had no signifi-
cant effect on FMDV infectivity; However, truncation of
side chains involved in a larger number of presumably stron-
ger interprotomer interactions led to a wide range of effects,
from dramatic (Group I) to none at all (Group IV). This
observation suggested that the detrimental effect on virus
infectivity of some mutations at these interfaces could be
due not to impaired assembly of protomers to yield
pentamers, but to the participation of the mutated residues
in some other stage of the viral cycle. As some of these resi-
dues participate also in intraprotomer and/or intraprotein
interactions, impaired protomer folding, a prerequisite for
interprotomer association, was a most likely candidate.
To determine if host cells transfected with any of the 21
mutant viral RNAs were able to yield folded capsid proto-
mers, we carried out in situ immunofluorescence assays of
cells transfected and analysed a short time p.t. Equal
amounts of mutant viral RNA and the non-mutated control
RNA were used, and the presence of folded protomers
(either free or associated as pentamers or assembled viral
particles) was estimated with mAb 5C4. This mAb recog-
nizes a discontinuous epitope that is present in folded pro-
tomers but not in unfolded protomers or denatured or
native individual capsid proteins. Fig. 2(a) shows results
with some representative mutants of each infectivity
group, compared with the non-mutated control. The com-
plete results are summarized in Table 2. As expected, the
vast majority of the 16 mutations that either had no effect
on infectivity or only delayed it (Groups IV and III, respect-
ively) also had no significant effect on the immunofluores-
cence signal, which probes for folded protomer (the only
exceptions were Y1107A, T3016A, I3143A and N2047A,
which had a minor effect). In contrast, mutation Y2100A,
which led to significantly reduced infectivity (Group II),
also reduced the immunofluorescence signal significantly,
and lethal mutations (Group I), except R2167A, led to no
detectable signal, or a drastically reduced signal.
In another immunofluorescence experiment, mutants with
reduced infectivity were probed with mAb SD6, which recog-
nizes a continuous epitope in VP1, irrespective of the state of
this capsid protein (unfolded or folded, free or associated in
Table 1. Residues at the FMDV capsid interprotomer interfaces chosen for mutational analysis
Residue* Hydrogen bondsD Charge–charge
interactionsD
VdW contactsD Exposed
side chain
Group according to
infectivityd
R2167 1sc (D3166) 1sc (D3166) 3 (0) No I
K2217 1sc (E3138) 1sc (E3138) 4 (2) Yes I
Q3100 1sc (T1120) 3 (0) No I
Y3169 1sc (N1091) 11 (5) No I
Y2100 16 (10) No II
K1085 1sc (E1175) 3 (0) Yes III
N2047 1sc (26S3163) 13 (0) No III
L2051 5 (4) No III
M3014 6 (3) No III
T1050 1mc (A1207) 9 (2) Yes IV
N1060 1sc (T1102) 2 (0) Yes IV
N1100 1mc (R3218) 4 (2) Yes IV
T1102 1sc (N1060) 12 (5) Yes IV
Y1107 9 (8) No IV
S2049 1mc (26Y3161) 10 (0) No IV
N3013 1sc (T1113) 9 (2) No IV
T3016 3sc (T1101, N1103,
36T1105)
11 (1) Yes IV
T3099 1sc (N1091) 9 (4) No IV
M3130 3 (1) Yes IV
I3143 5 (4) No IV
V3215 3 (2) No IV
*For each residue, the first digit indicates the protein (either VP1, VP2 or VP3) and the last three digits the amino acid position according to Lea
et al. (1994).
DFor each residue, the interprotomer interactions are indicated. The cut-off distance for hydrogen bonds was 3.5 A˚, for charge–charge interactions
3.9 A˚, and for VdW contacts 0.5 A˚ longer than the sum of the VdW radii of the two atoms considered. sc, Side chain; mc, main chain. The total
number of VdW contacts and, in parentheses, the number of carbon–carbon contacts are indicated.
dResidues are assigned to groups according to the effects that truncation of their side chain (by mutation to alanine) had on FMDV infectivity.
Group I, no detectable virus titre; Group II, reduced virus titres; Group III, delayed virus production; Group IV, normal virus titres (see text
and Table 2).
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protomers, pentamersor capsids).Weobserved a reduction in
the total amount of capsid protein that paralleled the
reduction observed with antibody 5C4 (results not shown).
The immunofluorescence results suggest that the reduced
infectivity observed in a minor fraction of the mutants
tested could be due to: (i) impaired RNA replication (leading
to a reduction in the amount of template RNA available for
translation); (ii) impaired capsid protein translation; or (iii)
proteolytic degradation of unfolded protomers that cannot
fold properly because of the mutation. We consider it
highly unlikely that all of these mutations in widely separate
positions in the capsid protein coding regions of the FMDV
Table 2. Effects on infectivity and capsid protomer assembly of mutations to alanine at the interprotomer interfaces in the FMDV
capsid
Virus* Relative virus titreD Lysis plaque
sized
Relative fluorescence
signal§
Conservation (%)I
45 h p.t. 55 h p.t. 72 h p.t.
Parental (wt) 1 1 1 Large 1 –
Group I
R2167A Lethal Lethal Lethal No 0.71¡0.23 100
K2217A Lethal Lethal ND No 0* 100
Q3100A Lethal Lethal Lethal No 0* 80
Y3169A Lethal Lethal Lethal No 0.11¡0.05* 100
Consensus or mean Lethal Lethal Lethal No 0.21 95
Group II
Y2100A 0.021¡0.008 0.024¡0.008 0.083¡0.001 Small 0.47¡0.03* 98
Mean or consensus 0.021 0.024 0.083 Small 0.47 98
Group III
K1085A 0.010¡0.001 0.128¡0.012 2.500¡0.141 Large 0.81¡0.02 40
N2047A 0.002¡0.001 0.009¡0.002 0.240¡0.007 Small 0* 100
L2051A 0.001¡0.001 0.007¡0.001 0.250¡0.007 Small 0.91¡0.05 100
M3014A 0.002¡0.002 0.016¡0.004 0.700¡0.03 Small 0.71¡0.03 28
Consensus or mean 0.004 0.040 0.925 Small 0.61 67
Group IV
T1050A 0.228¡0.047 0.600¡0.154 1.000¡0.141 Large 0.88¡0.05 41
N1060A 6.309¡0.223 7.692¡2.81 7.700¡0.494 Large 0.93¡0.11 38
N1100A 9.779¡0.892 3.077¡0.362 ND Large 0.82¡0.04 71
T1102A 0.154¡0.018 0.340¡0.125 0.400¡0.014 Large 0.73¡0.07 46
Y1107A 0.379¡0.664 0.577¡0.123 1.150¡0.106 Large 0.45¡0.18* 73
S2049A 1.067¡0.660 0.750¡0.353 ND Large 1.01¡0.07 94
N3013A 0.946¡0.167 1.769¡0.344 ND Large 0.98¡0.03 28
T3016A 2.000¡0.098 1.739¡0.212 ND Large 0.60¡0.09* 81
T3099A 0.268¡0.126 4.103¡0.025 1.300¡0.001 Large 0.98¡0.03 89
M3130A 0.857¡0.409 2.250¡0.106 0.400¡0.189 Large 0.97¡0.02 60
I3143A 0.763¡0.093 1.731¡0.74 6.000¡0.353 Large 0.63¡0.11* 99
V3215A 1.500¡0.555 2.100¡0.883 0.300¡0.190 Large 0.82¡0.003 61
Mean or consensus 2.0 2.2 2.3 Large 0.82 65
*Virus mutants are classified into groups I, II, III or IV according to the effects of the mutation on infectivity. For each group, the means of the
values obtained for the mutants in that group are also indicated.
DViral titres obtained at different times p.t. have been normalized relative to that obtained for the parental virus (wt). The mean absolute titres
obtained for the wt virus were (1.7¡0.4)6107 p.f.u. ml21 (45 h p.t.), (1.9¡0.3)6107 p.f.u. ml21 (55 h p.t.) and (2.3¡1.4)6107 p.f.u. ml21
(72 h p.t.). ND, Not determined.
dViruses that yielded plaques with mean sizes similar to or less than half that of the parental virus are respectively classified as large or small. No, no
plaques were detected.
§The relative fluorescence signal in in situ experiments (see text and Fig. 2) was determined by dividing the number of cells that were positive with
mAb 5C4 by the total number of cells analysed, and dividing those relative values by that obtained for the parental virus (wt). The final normalized
value obtained for each mutant gives an indication of the mean relative amount of capsid protomers assembled in the cells. The data were analysed
using a one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test. Values that are significantly different (P,0.01) from the wt value
are indicated by an asterisk.
IPercentage conservation is given relative to both the consensus residue and the residue found in CS8c1, except for N1060, for which conservation
is indicated relative to consensus (9 % relative to CS8c1).
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T1050A N1100A T1102A
T3099A
M3014A
Y3169AR2167AY2100A
S2049A
L2051A
Y1107A
K1085A
wt
Fig. 2. In situ immunofluorescence analysis of the presence of FMDV in cells transfected with viral RNA carrying mutations at
the interprotomer interfaces: detection of folded protomers (either free or as a part of larger structures). The pictures show
representative results with negative (mock) or positive (wt, non-mutated viral RNA) controls, or with examples of Group IV
(T1050A, N1100A, T1102A, Y1107A, S2049A, T3099A), Group III (K1085A, L2051A, M3014A), Group II (Y2100A) or
Group I (R2167A, Y3169A) mutants. Green and blue fluorescence correspond, respectively, to the signal obtained for folded
protomers using mAb 5C4, or to DAPI staining. A summary of the results obtained in these experiments with the 21 mutants
tested is included in Table 2.
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genome affect RNA replication or translation. Thus, though
further study is required, we tentatively favour the possibility
that the observed reduced infectivity is due to a defect in pro-
tomer folding. Whatever the early step affected in these
mutants, the results revealed that protomer–protomer associ-
ation during FMDV assembly is not substantially affected by
(nearly) any of the mutations analysed in this study.
Effect of individual mutations at the interprotomer
interfaces on the stability of infectious FMD
virions
FMDV is easily heat-inactivated, even at physiological tem-
perature. We analysed whether removal of interprotomer
interactions in non-lethal mutant virions with reduced
(Group II) or delayed (Group III) infectivity could decrease
their resistance to heat-induced inactivation. Fig. 3 shows
the inactivation kinetics of most Group II and III virions
at 42 uC. Fitting to exponential decay reactions revealed
only very small or non-significant differences in the inacti-
vation rate constant between any of these mutants and the
non-mutated virion. Thus, the observed reduction or delay
in progeny virus titres by these mutations is not a conse-
quence of a significant destabilization of the infectious
virions obtained as final products.
Analysis of residue conservation at interprotomer
and interpentamer interfaces in FMDV
The comparative residue-by-residuedissection of interproto-
mer interfaces (this study), and interpentamer interfaces in
the following assembly step (Mateo et al., 2003), in FMDV
revealed quite different relationships between structure,
interactions and functional effects. To determine whether
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Fig. 3. Thermal inactivation kinetics at 42 8C of viruses carrying mutations at the interprotomer interfaces. In each panel,
circle symbols correspond to the non-mutated control virion, and square symbols correspond to a Group II or Group III
mutant virion as follows: (a) K1085A; (b) N2047A; (c) Y2100A; (d) M3014A. Values given and error bars correspond,
respectively, to means¡SD obtained in two or three independent experiments. Error bars smaller than the size of the symbols
used are not represented. Fitting of the experimental data to an exponential decay in viral titer is indicated by solid lines.
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these substantial differences could be reflected in the way
these interfaces had varied during FMDV evolution, we
carried out a sequence comparison analysis of 250 strains of
the seven FMDV serotypes identified.
Interprotomer interfaces showed a degree of residue con-
servation that could be qualitatively related overall with
the observed effects of individual mutations on infectivity
(Table 2). Group I and II residues, whose mutation to
alanine proved to be lethal or severely impaired infection,
showed a mean conservation of 95–98 %; in contrast,
Groups III and IV residues, whose mutation did not
prevent normal infectivity (or, in some cases, only delayed
virus production), showed a mean conservation of
67–65 %. The global mean conservation of residues at the
interprotomer interfaces was 72 %, which is remarkably
lower than the mean conservation of capsid regions
known to be involved in functional steps of the infectious
cycle different from protomer–protomer association.
Residue-by-residue analysis of the interpentamer interfaces
had revealed that, contrary to that observed for interproto-
mer interfaces, individual mutation to alanine of the vast
majority (81 %) of the 42 residues tested was lethal or
severely impaired infectivity. Accordingly, the global
mean conservation of these 42 residues is very high
(93 %), much higher than that of the residues at the inter-
protomer interfaces (72 %). From their effect on infectiv-
ity, mutations to alanine at the interpentamer interfaces
were classified also into four groups. Interestingly, these
groups showed similar mean conservation: 96 % (Group
I, lethal mutations), 85 % (Group II, strong reductions in
infectivity with partial recovery), 88 % (Group III, signifi-
cant reductions in infectivity) and 92 % (Group IV, no sig-
nificant reduction in infectivity). Thus, contrary to what
was observed for interprotomer interfaces, for interpenta-
mer interfaces no overall correlation was found between
residue conservation and effect on FMDV infectivity.
Based on the results of our structure–function analyses,
we present in the Discussion a hypothetical comparative
model with different selective constraints in the different
interfaces in the FMDV capsid.
DISCUSSION
Robust interprotomer interfaces within FMDV
pentameric subunits
The results of this study revealed that most amino acid side
chains involved in substantial interactions between proto-
mers within each pentamer in the FMDV capsid are not
individually required for virus infectivity. This functional
tolerance to disruption of interprotomer interactions was
unexpected, as this interface may be considered to be struc-
turally similar to typical protein–protein interfaces. The
interprotomer interface is narrow and very elongated
rather than roughly circular, but it is still essentially
made up of a central, buried hydrophobic region
surrounded by a rim of solvent-exposed polar residues
(Fig. 1b). In typical protein–protein interfaces, a number
of buried hydrophobic side chains provide energetic hot-
spots that are individually critical for the interaction
(Bogan & Thorn, 1998), while no such hotspots were
detected in the FMDV interprotomer interfaces.
Two structural differences with typical protein–protein
interfaces may contribute to the absence of energetic hot-
spots in the protomer–protomer interfaces in the FMD
virion: (i) the high number of residues and interactions
involved in each of these interfaces (about twice the typical
number in interfaces between interacting cellular proteins,
or in small oligomers), probably leading to high binding
affinity; (ii) the high proportion of main chain–main
chain interactions (directly insensitive to mutation) that
contribute to protomer–protomer binding.
The reduction of viral infectivity caused by individual
mutation of a few residues at these interfaces was related
mainly to an effect on an early stage of the viral cycle, as
the amount of folded protomers was significantly reduced.
These few functionally important residues do not form a
single discrete patch on the FMDV capsid surface
(Fig. 1c), which suggests they may not be involved in bind-
ing some unidentified molecule during the viral cycle.
A likely, albeit still unproven, explanation is that these
residues could impair folding of the unprocessed capsid
polyprotein, leading to its early degradation in the cell,
before virus assembly begins, leading to reduced amounts
of folded protomers (and, thus, pentamers) available for
capsid assembly.
Different tolerance to mutation at interprotomer
and interpentamer interfaces in the FMD virion
Comparison of the results obtained by alanine-scanning of
the interprotomer interfaces and interpentamer interfaces
in the same FMD virion revealed remarkable functional
differences. On the one hand, assembly of protomers into
pentamers is essentially insensitive to the loss of inter-
actions between nearly any side chain in one protomer
and residues in the neighbouring protomer. On the other
hand, assembly of pentamers into complete capsids or vir-
ions is critically dependent on the individual interactions
between most side chains in one pentamer and residues
in the neighbouring pentamer.
Structurally, these different sensitivities to removal of inter-
facial interactions may be a consequence of the different
organization of interprotomer versus interpentamer inter-
faces. In the interprotomer interfaces, the high number of
strong protein–protein interactions, including burial of a
large hydrophobic surface area, may make any individual
interaction, however strong, of comparatively little
relevance for the global interaction. In contrast, the inter-
pentamer interfaces involve fewer residues and are made
almost exclusively by polar residues involved in weaker
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interactions. In this context, the individual removal of even
the weakest interactions can have a significant effect.
From the viewpoint of biological evolution, this quite differ-
ent structural organization of different interfaces in a virion,
and the corresponding functional differences in two consecu-
tive steps of virion assembly, could be the result of different
selective pressures. Once assembled, pentamers need not be
disassembled into protomers for genome uncoating or any
other stage in the infectious cycle. Thus, selection may
have favoured energetically strong interfaces between proto-
mers that are quite insensitive to single mutations. In the
infected cell, this would ensure the maximum availability
of fully formed, assembly-competent pentameric building
blocks to reach the critical concentration and amounts
needed to form many virions per cell. Interprotomer inter-
faces that were functionally rather sensitive to mutation, in
the face of the very high mutation rate characteristic of
RNA viruses, including FMDV (Domingo et al., 2004),
would frequently lead to reduced amounts of assembly-com-
petent pentameric building blocks. The relatively low conser-
vation of most residues at the FMDV interprotomer
interfaces is also consistent with this scenario. In these inter-
faces, only those few residues that happen to have a role in
other stages of the viral cycle are highly conserved.
In contrast to pentameric subunits, complete FMD virions
assembled from them do need to be disassembled for
genome uncoating. This, it could be sensibly thought that
FMDV could have evolved its essentially polar, energetically
weak interpentamer interfaces for facilitating uncoating.
Uncoating occurs by mild acidification in the endosomes
(Va´zquez-Calvo et al., 2012) and is mediated by repulsions
between a few histidines that become fully protonated
(Acharya et al., 1989; Curry et al., 1995; Ellard et al., 1999;
Maree et al., 2013; van Vlijmen et al., 1998). It could be
thought that these repulsions could suffice to unbind the
pentamers only if the interactions between the latter are
intrinsically weak enough. However, engineered thermostable
FMD virions in which the net strength of association between
pentamers was increased were as infectious as the natural,
thermolabile ones (Mateo et al., 2008; Rinco´n et al., 2014).
Thus, the conserved structural instability of natural FMD vir-
ions may be partly due to an unidentified selective pressure
unrelated to uncoating (Hegde et al., 2009). Although the
selective pressure behind weak interpentamer interfaces in
the FMDV virion is unclear, the inevitable tradeoff of such
weakness is that loss of a few intersubunit interactions may
suffice to tilt the energetic balance and promote dissociation
outside the cell, making these interfaces extremely sensitive to
single mutations as observed. The high conservation of the
vast majority of residues at the interpentamer interfaces in
infectious FMDV variants is consistent with this scenario.
Comparison with intersubunit interfaces in other
spherical viruses
Very few interfaces between subunits in viral particles have
been systematically analysed through mutational analysis
so far. However, the structure-based functional differences
between different interfaces in the FMD virion may be
compared with those found during our analysis of another
small spherical virus of another family, the parvovirus
minute virus of mice (MVM) (Reguera et al., 2004; Pe´rez
et al., 2011). The results indicate that, in both MVM and
FMDV, very stable building blocks (trimers and pentamers
of subunits, repectively) are formed in high-affinity associ-
ation reactions that are, to a remarkable extent, mutation-
insensitive. In both viruses, those building blocks self-
associate to form the viral capsid in lower-affinity reactions
that are, to different extents, mutation-sensitive.
The differences between viruses in sensitivity to mutation
at the intersubunit interfaces may be equally revealing.
In MVM, a very stable virion that does not require
capsid disassembly for genome uncoating (Cotmore &
Tattersall, 2012), intertrimer association depends critically
only on a few hotspot residues that establish strong inter-
actions, and is relatively insensitive to mutation at the
intertrimer interfaces. In FMDV, a labile virion that
requires capsid disassembly for uncoating, interpentamer
association depends critically on many residues, even
those that establish weak interactions, and is much more
sensitive to mutation at these interfaces. This high
functional sensitivity to mutation at the interpentamer
interfaces in FMDV may, however, be not as detrimental
to virus evolution as could be expected. Remarkably, the
virus manages to accept the introduction of many lethal
mutations at these interfaces by fixation of compensatory
mutations that frequently occur at a few ‘compensation
hotspots’ in defined locations of the viral capsid (Luna
et al., 2009). These and other studies have revealed diverse
structural adaptations at the interfaces between subunits in
viral capsids that allow them to perform the required func-
tions during the viral cycle using different mechanisms and
evolutionary strategies.
METHODS
Site-directedmutagenesis and subcloning. Substitution of amino
acid residues in the FMDV capsid (strain C-S8c1) (Sobrino et al., 1983;
GenBank sequence accession number AJ133357) was carried out in
plasmid p3242/C-S8c1 (Baranowski et al., 1998) using the QuikChange
system (Stratagene). The mutagenized segments were subcloned in the
infectious plasmid pO1K/C-S8c1 essentially as previously described
(Mateo & Mateu, 2007; Mateo et al., 2003). The presence of the
engineered mutations and absence of any other mutation in the sub-
cloned segment were confirmed by DNA sequencing.
Transcription of viral RNA and transfection of eukaryotic cells.
FMDV RNA was transcribed from linearized non-mutated and
mutant pO1K/C-S8c1 plasmids by using the Riboprobe in vitro
transcription system (Promega), and used to transfect BHK-21 cells
by electroporation as previously described (Mateo & Mateu, 2007;
Mateo et al., 2003). The same amounts of every mutant RNA, and
of non-mutated RNA as a control, were used in each experiment.
Progeny virions were recovered after complete cytopathic effect at
different times p.t.
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Determination of virus infectivity, amplification of viruses and
extraction of viral RNA. Titrations of viruses obtained by transfec-
tion of BHK-21 cells were determined at least in duplicate in standard
plaque assays. When needed, progeny viruses were amplified by a
minimumnumber of passages in BHK-21 cellmonolayers at the highest
possible m.o.i., and titrated again. RNA derived from viral populations
obtained by transfection or infection was extracted using Trizol LS
(Invitrogen) and precipitated with 2-propanol. The RNA was reverse-
transcribed to DNA and amplified by PCR as previously described
(Mateo & Mateu, 2007; Mateo et al., 2003). The reverse transcription
PCR products were purified using centrifugal filter units Amicon Ultra
(Millipore). The presence of mutations in the progeny virions was
detected by sequencing the capsid region or the entire genome.
Thermal inactivation assays. One millilitre aliquots of virus sus-
pensions adjusted to a titre of 2|107 to 4|107 p.f.u. x ml21 were
clarified by centrifugation at 10 000 g for 10 min and subsequently
heated at 42 uC for different lengths of time. In general, a mutated
virus and the non-mutated control in the same experiment were
purified and processed in parallel, to exclude possible differences in
the dissociation rate due to slightly differing final conditions between
preparations and experiments. The experimental data were fitted to
first-order exponential decays by using the program Kaleidagraph
(Sinergy Software), which allowed the determination of the dis-
sociation rate constant under the conditions tested (Mateo et al.,
2008).
In situ immunofluorescence assays. BHK-21 cells were electro-
porated with viral RNA as described above, and subsequently cultured
on coverslips incubated for 30 h at 37 uC. These were washed with
PBS, incubated with 4 % paraformaldehyde, washed again, and
incubated with 10 mM glycine–NaOH, pH 8.5. The cell membranes
were permeabilized by incubation with 0.2 % Triton X-100 in PBS.
The coverslips were washed again, incubated in PBS containing 3 %
BSA, and then incubated for 1 h at room temperature with mono-
clonal antibody 5C4 diluted 1 : 500 in PBS with 3 % BSA. 5C4
recognizes a discontinuous epitope present on the virus particle
surface (Lea et al., 1994), and unassembled capsid pentamers and
protomers (Sa´iz et al., 1994), but not in isolated capsid proteins. The
coverslips were washed thoroughly, and incubated with one or more
secondary antibodies diluted 1 : 500 in PBS containing 3 % BSA.
Subsequently, the samples were washed and incubated with 1 mg ml21
DAPI (Calbiochem) in PBS for 3 min, washed again, mounted, and
visualized in a fluorescence microscope. The percentage of cells that
showed fluorescence above detection level with mAb 5C4 relative to
total cells (positive for DAPI) was calculated. This method has been
repeatedly used by different groups (Ventoso et al., 2010; Poenisch
et al., 2015; Lombardo et al., 2000; Martı´n-Acebes et al., 2009;
Popescu et al., 2011) and provides a good estimate of the antigen
expressed (folded protomer in this case). Statistical analysis (Table 2)
was performed using KaleidaGraph.
Molecular graphics, structural analyses and sequence com-
parisons. The Protein Data Bank atomic coordinates for the crystal
structure of FMDV C-S8c1 (1fmd) (Lea et al., 1994) were inspected
graphically using the programs InsightII (Biosym Technologies),
RASMOL (Sayle & Milner-White, 1995) and/or Pymol (DeLano, 2002).
Contact and solvent accessibility analyses were carried out using the
program WHAT IF (Vriend, 1990). Sequence conservation analysis of
capsid proteins corresponding to 250 FMDV isolates and deposited in
the GenBank (NCBI) was carried out using the alignment program
CLUSTAL W (EMBL-EBI).
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